Immunthrombozytopenie

Suche

Titel

A Phase II, randomized (1:1) open label study to assess the efficacy and safety of eltrombopag in combination with dexamethasone compared to dexamethasone, as first-line treatment in adult patients with newly diagnosed immune thrombocytopenia

Indikation

Primäre Immunthrombopenie

Art der Studie

Therapiestudie, Interventionell, Phase 2

Therapielinie

Erstlinientherapie

Hauptprüfer am Zentrum (PI)

Prof. Dr. med. M. Binder

Ansprechpartner

Frau S. Edemir

Telefon: 0345/ 557 3170

Mail: sabine.edemir@uk-halle.de